Vl Vaccines Inc is categorized under Commercial Biotechnical Research in Gaithersburg, MD and active since 2012.
Vl Vaccines Inc was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Jim Meade at the company’s single location by writing to 910 Clopper Road, Gaithersburg, Maryland MD 20878 or by phoning (301) 527-4200. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Vl Vaccines Inc |
| Contact Person: | Jim Meade |
| Address: | 910 Clopper Road, Gaithersburg, Maryland 20878 |
| Phone Number: | (301) 527-4200 |
| Website Address: | lentigen.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541711 |
| Share This Business: |
Vl Vaccines Inc was started in 2012 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Jim Meade for inquiries that concern Vl Vaccines Inc by calling the company number (301) 527-4200, as your correspondence is most welcome. Additionally, the physical location of the single location of Vl Vaccines Inc can be found at the coordinates 39.147058,-77.230774 as well as the street address 910 Clopper Road in Gaithersburg, Maryland 20878.
For its online presence, you may visit Vl Vaccines Inc’s website at lentigen.com and engage with its social media outlets through on Twitter and on Facebook.